Novartis AG
NYSE:NVS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Novartis AG
NYSE:NVS
|
CH |
|
E
|
Expeditors International of Washington Inc
XMUN:EW1
|
US |
|
Agricultural Bank of China Ltd
F:EK7
|
CN |
|
PriceSmart Inc
NASDAQ:PSMT
|
US |
|
OUTFRONT Media Inc
F:76C0
|
US |
|
T
|
Thai Union Feedmill PCL
SET:TFM
|
TH |
|
T
|
Technip Energies NV
OTC:THNPY
|
FR |
|
C
|
Continental AG
MIL:CON
|
DE |
|
D
|
DS Smith PLC
OTC:DITHF
|
UK |
|
E
|
Elis SA
OTC:ELSSF
|
FR |
|
Advantest Corp
TSE:6857
|
JP |
|
A
|
AXA SA
LSE:0HAR
|
FR |
Wall St Price Targets
NVS Price Targets Summary
Novartis AG
According to Wall Street analysts, the average 1-year price target for NVS is 159.48 USD with a low forecast of 117.8 USD and a high forecast of 188.4 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NVS's stock price target?
Price Target
159.48
USD
According to Wall Street analysts, the average 1-year price target for NVS is 159.48 USD with a low forecast of 117.8 USD and a high forecast of 188.4 USD.
What is the Revenue forecast for Novartis AG?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Novartis AG?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 8 years is 6%.
What is the Net Income forecast for Novartis AG?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 8 years is 7%.
